A Clinical Study of Belzutifan (MK-6482) Alone or With Phenytoin in Healthy Participants (CA46602/MK-6482-035)
Clinical trial NCT06903715 · COMPLETED
Trial details
- NCT number
- NCT06903715
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-28
- Primary completion
- 2025-05-08
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.